Colorectal Cancer Trial, Recruiting NCT05879783 Sponsor: Nanfang Hospital, Southern Medical University Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05879783
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 84 years old
  • People who have been assessed by an anaesthesiologist as being in a generally healthy to mildly-to-moderately compromised health state before surgery (known as ASA class I, II, or III — confirm with trial site if unsure)
  • People who have been diagnosed with colorectal cancer
  • People who are scheduled to have surgery as part of their treatment
  • People who are willing and able to provide written consent to participate

Who may not be able to join:

  • Women who are pregnant or currently breastfeeding
  • People who have acute kidney failure, or moderate to severe long-term kidney disease (classified as stage II to IV chronic kidney insufficiency)
  • People who have serious liver damage or liver disease
  • People who have asthma, or who are known to have a history of significant allergic reactions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jun Yan, M.D., Ph.D., Nanfang Hospital, Southern Medical University

Phone: 086-13825066546

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanfang Hospital, Southern Medical University
Registry
ClinicalTrials.gov
Start date
15 September 2022
Est. completion
15 September 2023

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Accuracy of pCLE optical biopsy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov